NYSE:CO - Global Cord Blood Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $6.30 -0.02 (-0.32 %) (As of 10/23/2018 04:00 PM ET)Previous Close$6.32Today's Range$6.27 - $6.4052-Week Range$6.24 - $12.44Volume66,870 shsAverage Volume94,059 shsMarket Capitalization$797.20 millionP/E Ratio21.32Dividend Yield1.21%Beta0.38 ProfileDiscussionChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership). Receive CO News and Ratings via Email Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Holding & other investment offices Sub-IndustryN/A SectorMedical Current SymbolNYSE:CO Previous Symbol CUSIPN/A Webwww.globalcordbloodcorp.comen_us Phone852-3605-8180 Debt Debt-to-Equity RatioN/A Current Ratio8.43 Quick Ratio8.36 Price-To-Earnings Trailing P/E Ratio21.32 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$149.34 million Price / Sales5.09 Cash Flow$0.3633 per share Price / Cash17.34 Book Value$4.12 per share Price / Book1.53 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$37.79 million Net Margins25.36% Return on Equity7.79% Return on Assets4.15% Miscellaneous Employees1,196 Outstanding Shares120,610,000Market Cap$797.20 million OptionableN/A Global Cord Blood (NYSE:CO) Frequently Asked Questions What is Global Cord Blood's stock symbol? Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO." How often does Global Cord Blood pay dividends? What is the dividend yield for Global Cord Blood? Global Cord Blood announced an annual dividend on Tuesday, June 26th. Investors of record on Monday, July 30th will be paid a dividend of $0.08 per share on Monday, August 20th. This represents a yield of 0.93%. The ex-dividend date of this dividend is Friday, July 27th. View Global Cord Blood's Dividend History. How were Global Cord Blood's earnings last quarter? Global Cord Blood Corp (NYSE:CO) posted its earnings results on Thursday, August, 23rd. The medical research company reported $0.09 EPS for the quarter. The medical research company earned $35.34 million during the quarter. Global Cord Blood had a net margin of 25.36% and a return on equity of 7.79%. View Global Cord Blood's Earnings History. When is Global Cord Blood's next earnings date? Global Cord Blood is scheduled to release their next quarterly earnings announcement on Monday, November 19th 2018. View Earnings Estimates for Global Cord Blood. Who are some of Global Cord Blood's key competitors? Some companies that are related to Global Cord Blood include Alta Mesa Resources (AMR), TPG PACE ENERGY/SH CL A (TPGE), GTY Technology (GTYH), Vantage Energy Acquisition (VEAC), Pensare Acquisition (WRLS), Falcon Minerals (FLMN), AgroFresh Solutions (AGFS), Modern Media Acquisition (MMDM), Forum Merger Ii Cl A (FMCI), FINTECH ACQUISI/SH (FNTE), KBL MERGER Corp/SH (KBLM), TMSR (TMSR), STELLAR ACQUISI/SH SH (STLR), Jetpay (JTPY) and STG Group (STGG). Who are Global Cord Blood's key executives? Global Cord Blood's management team includes the folowing people: Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 46)Mr. Albert Chen, CFO & Director (Age 42)Ms. Xin Xu, Chief Technology Officer (Age 64)Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 59)Ms. Cathy Bai, VP of Corp. Fin. How do I buy shares of Global Cord Blood? Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Global Cord Blood's stock price today? One share of CO stock can currently be purchased for approximately $6.30. How big of a company is Global Cord Blood? Global Cord Blood has a market capitalization of $797.20 million and generates $149.34 million in revenue each year. Global Cord Blood employs 1,196 workers across the globe. What is Global Cord Blood's official website? The official website for Global Cord Blood is http://www.globalcordbloodcorp.com/en_us. How can I contact Global Cord Blood? Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected] MarketBeat Community Rating for Global Cord Blood (NYSE CO)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 167 (Vote Outperform)Underperform Votes: 184 (Vote Underperform)Total Votes: 351MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/23/2018 by MarketBeat.com StaffFeatured Article: What is a Call Option?